A recent study revealed that NK cells modified to express IL-21 maintained their anti-tumor activity against glioblastoma over time, whereas IL-15 armored NK cells were more prone to exhaustion after multiple tumor re-challenges [25]. The gene discussed is IL15; the disease is neoplasm.